Synergy Shield Coronary Stent 2.50 X 8 | REF H7493966608250
Boston Scientific Synergy Shield Coronary Stent, 2.50 mm x 8 mm (REF H7493966608250) for B2B medical device procurement.
The Terumo Ultimaster Nagomi Coronary Stent (REF DE-RQ2209KSM) is a sirolimus-eluting coronary stent system in a 2.25 mm × 9 mm configuration, pre-mounted on a rapid-exchange delivery catheter. It is part of Terumo's Ultimaster family of bioresorbable polymer drug-eluting stents intended for percutaneous coronary intervention.
Key Features
- Cobalt-chromium thin-strut stent platform designed for deliverability and conformability
- Sirolimus drug coating combined with a bioresorbable PDLLA-PCL polymer applied to the abluminal surface
- Abluminal-only coating intended to limit polymer exposure to the vessel lumen
- Pre-mounted on a rapid-exchange (monorail) delivery catheter
- Small-vessel size option at 2.25 mm diameter, 9 mm length
- Single-use, sterile (ethylene oxide) packaging
Clinical Applications
- Percutaneous coronary intervention in native coronary arteries
- Treatment of small-diameter coronary lesions where a 2.25 mm device is appropriate
- Short-segment lesion coverage suited to the 9 mm stent length
- Use as part of standard interventional cardiology catheterization lab procedures
Product Information
- Brand: Terumo
- Product line: Ultimaster Nagomi
- Category: Coronary Stents (drug-eluting)
- REF / UPN: DE-RQ2209KSM
- Stent diameter: 2.25 mm
- Stent length: 9 mm
- Drug: Sirolimus
- Polymer: Bioresorbable (PDLLA-PCL), abluminal coating
- Delivery system: Rapid-exchange catheter
- Guide wire compatibility: Not specified in the located sources
- Guiding catheter compatibility: Not specified in the located sources
- Sterilization: Sterile, single use
- Regulatory status: Refer to official Terumo IFU and regional regulatory documentation
REF / UPNDE-RQ2209KSM
Size9 mm
Terumo Ultimaster NagomiUltimaster Nagomi stentcoronary stent 2.25 x 9 mmsirolimus eluting stentdrug eluting stentbioresorbable polymer stentDES coronary stentsmall vessel coronary stentREF DE-RQ2209KSMTerumo coronary stentPCI stentinterventional cardiology stentabluminal coated stentrapid exchange stentB2B medical device procurement
How It Works
1
Submit Your Request
Tell us what product you need and share a few details.
2
We Match You
We connect your request with the most relevant verified brands.
3
Receive Offers
Relevant supplier options can respond with availability, documentation context, and quote details.
Related Products
Related products
Synergy Shield Coronary Stent 2.75 X 8 | REF H7493966608270
Boston Scientific Synergy Shield Coronary Stent, 2.75 mm x 8 mm (REF H7493966608270), available for B2B medical device procurement.
Synergy Shield Coronary Stent 3.00 X 8 | REF H7493966608300
Boston Scientific Synergy Shield Coronary Stent (3.00 mm x 8 mm), REF H7493966608300, supplied for B2B procurement.
Synergy Shield Coronary Stent 3.50 X 8 | REF H7493966608350
Boston Scientific Synergy Shield Coronary Stent, 3.50 mm x 8 mm (REF H7493966608350) for B2B medical device procurement.
Synergy Shield Coronary Stent 4.00 X 8 | REF H7493966608400
Boston Scientific Synergy Shield Coronary Stent, 4.00 mm x 8 mm (REF H7493966608400) for B2B medical device procurement.
Synergy Shield Coronary Stent 2.25 X 12 | REF H7493966612220
Boston Scientific Synergy Shield Coronary Stent, 2.25 mm x 12 mm (REF H7493966612220) for B2B medical device procurement.
Synergy Shield Coronary Stent 2.50 X 12 | REF H7493966612250
Boston Scientific Synergy Shield Coronary Stent, 2.50 mm x 12 mm (REF H7493966612250) for B2B medical device procurement.
Synergy Shield Coronary Stent 2.75 X 12 | REF H7493966612270
Boston Scientific Synergy Shield Coronary Stent, 2.75 mm x 12 mm (REF H7493966612270) for B2B medical device procurement.
Synergy Shield Coronary Stent 3.00 X 12 | REF H7493966612300
Boston Scientific Synergy Shield Coronary Stent, 3.00 mm x 12 mm (REF H7493966612300) for B2B medical device procurement.
Synergy Shield Coronary Stent 3.50 X 12 | REF H7493966612350
Boston Scientific Synergy Shield Coronary Stent, 3.50 mm x 12 mm (REF H7493966612350) for B2B medical device procurement.
Synergy Shield Coronary Stent 4.00 X 12 | REF H7493966612400
Boston Scientific Synergy Shield Coronary Stent, 4.00 mm x 12 mm, REF H7493966612400, supplied for B2B procurement.
Synergy Shield Coronary Stent 4.50 X 12 | REF H7493966612450
Boston Scientific Synergy Shield Coronary Stent, 4.50 mm x 12 mm (REF H7493966612450) for B2B medical device procurement.
Synergy Shield Coronary Stent 5.00 X 12 | REF H7493966612500
Boston Scientific Synergy Shield Coronary Stent, 5.00 mm x 12 mm (REF H7493966612500), supplied for B2B medical device procurement.
Synergy Shield Coronary Stent 2.25 X 16 | REF H7493966616220
Boston Scientific Synergy Shield Coronary Stent, 2.25 mm x 16 mm (REF H7493966616220), supplied for B2B procurement.
Buyer support
Frequently asked questions about Ultimaster Nagomi Coronary Stent 2.25 × 9 mm | REF DE-RQ2209KSM
Practical answers for procurement teams reviewing this product page.
Include the exact product family, brand preference, REF/UPN code when available, required quantity, destination country, expected delivery timing and documentation expectations.
Yes. If alternatives are acceptable, mention equivalent brands, compatible models, size ranges and any non-negotiable requirements.
Related products are connected through structured catalog data such as brand, category, product family and country assignment.
No. This page supports sourcing and RFQ organization. Buyers must verify regulatory status, clinical suitability and procurement compliance independently.
Specific codes reduce ambiguity and help supplier teams identify product availability, packaging details and documentation faster.
Yes. The workflow is designed for hospitals, clinics, distributors, wholesalers, importers and procurement departments.
Yes. Products can be connected to multiple countries in the admin panel, and buyers can specify destination details in the RFQ form.
The request is stored with contact and procurement details so the sourcing conversation can be reviewed and followed up clearly.